Cargando…
Heparin-Induced Thrombocytopenia in COVID-19: A Systematic Review
BACKGROUND: It has been more than a year since the whole world is struggling with COVID-19 pandemic and may experience resurgences in the near future. Along with severe pneumonia, this disease is notorious for extensive thromboembolic manifestations. That is why experts advocated aggressive anticoag...
Autores principales: | Sulakshana, Sulakshana, Nayak, Sudhansu Sekhar, Perumal, Siva, Das, Badri Prasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004278/ https://www.ncbi.nlm.nih.gov/pubmed/35422550 http://dx.doi.org/10.4103/aer.aer_151_21 |
Ejemplares similares
-
Heparin-induced thrombocytopenia in patients with COVID-19: a systematic review and meta-analysis
por: Uaprasert, Noppacharn, et al.
Publicado: (2021) -
Extracorporeal Membrane Oxygenation for Severe COVID-19 in Indian Scenario: A Single Center Retrospective Study
por: Sulakshana, Sulakshana, et al.
Publicado: (2023) -
Anti-Voltage-Gated Potassium Channel Antibody Syndrome: A Rare Cause of Hyponatremia in Intensive Care Unit
por: Sulakshana, Sulakshana, et al.
Publicado: (2018) -
Nanotherapeutics in the treatment of acute respiratory distress syndrome
por: Prasanna, Pragya, et al.
Publicado: (2021) -
Heparin-Induced Thrombocytopenia in COVID-19
por: Lingamaneni, Prasanth, et al.
Publicado: (2020)